GSK3B and ovarian cancer: In triple-negative breast cancer, downregulation of circ-ITCH lifts repression on miR-17 and miR-214, enhancing pathway activation, and in ovarian cancer, loss of circFBXO7 promotes β-catenin accumulation and Glycogen Synthase Kinase 3 Beta (GSK3β) phosphorylation [27,28].